<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "mitomycin inj VIAL>
<dose><value>30 - 60</value>
<value>10</value>
<value>10 - 20</value>
</dose><route><value>INTRAVESICALLY</value>
<value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>mitomycin inj VIAL</value>
</drugname><strength><value>20 mg</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>Retain solution for 2 hours.</value>
<value>Administer dose by direct injection into free flowing infusion.</value>
</instruction><volume><value></value>
</volume><units><value>mg</value>
<value>mg/m2</value>
</units><additionalnotes><value>Bladder Cancer. Dilute dose in 50 mL sterile water for injection.</value>
<value>Squamous Cell Carcinoma of Anus. Maximum dose: 20 mg.</value>
<value>Doses greater than 20 mg/m2 do not demonstrate increased effectiveness and are more toxic than lower doses. Total cumulative doses of 50 to 60 mg/m2 are associated with increased risk of adverse effects (pulmonary toxicity and renal toxicity).</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3339</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Usage guidelines.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>